Skip to content
Dosage GuideResearch Reference

Vasopressin Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Vasopressin. All information is for educational purposes only.

Quick Answer

Vasopressin is typically administered intravenously in clinical settings. Dosing varies depending on the indication. For vasodilatory shock, it is generally administered as a continuous infusion. For diabetes insipidus, it may be administered intravenously, intramuscularly, or subcutaneously. Desmopressin, a synthetic analog, is available for oral, intranasal, and subcutaneous administration.

Standard Dosage Range

Research dosing range: 0.01–0.1 units/minute (vasodilatory shock); 5–10 units IV/IM/SC (diabetes insipidus); Desmopressin varies by formulation (diabetes insipidus)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Vasodilatory Shock (Septic Shock, Post-Cardiotomy)

0.01–0.04 units/minuteContinuous IV infusion
Duration

Until shock resolves (titrate to effect)

Titrate to maintain target MAP. Often used as an adjunct to norepinephrine or epinephrine. Higher doses (up to 0.1 units/minute) may be required in severe cases.

Central Diabetes Insipidus

5–10 units2–3 times daily
Duration

Chronic management

Administer IV, IM, or SC. Monitor fluid balance and serum sodium. Desmopressin is often preferred for long-term management due to longer half-life and alternative routes of administration.

Cardiac Arrest (ACLS Protocol)

40 unitsSingle IV/IO dose
Duration

One-time dose

Administer as a single IV/IO push. May be considered as an alternative to epinephrine or in conjunction with epinephrine in pulseless arrest.

Bleeding Esophageal Varices

0.2–0.4 units/minuteContinuous IV infusion
Duration

Up to 24 hours

Titrate to control bleeding. Often used in conjunction with other therapies such as octreotide and endoscopic banding.

Timing & Frequency

For vasodilatory shock, vasopressin is typically administered as a continuous infusion in the ICU setting. For diabetes insipidus, timing depends on the route of administration and the specific formulation used (e.g., desmopressin is often administered at bedtime to reduce nocturia).

Cycle Guidance

Vasopressin is typically used short-term for acute conditions like vasodilatory shock or bleeding esophageal varices. For chronic conditions like diabetes insipidus, desmopressin is preferred for long-term management.

Reconstitution Reference

Quick reference for reconstituting Vasopressin. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeTypically 20 units/mL or 100 units/mL
BAC Water VolumeNot applicable; comes pre-mixed for IV administration.
Concentration & DrawConcentration varies depending on the vial size (20 units/mL or 100 units/mL). Follow hospital protocols for dilution and administration.
StorageStore refrigerated at 2–8°C. Protect from light.
StabilityConsult product labeling for specific stability information.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the standard vasopressin dosage for septic shock?
The standard vasopressin dosage for septic shock is typically 0.01–0.04 units/minute as a continuous IV infusion, titrated to maintain a target MAP. Higher doses (up to 0.1 units/minute) may be required in severe cases.
How is vasopressin administered?
Vasopressin is typically administered intravenously in clinical settings. For diabetes insipidus, it may also be administered intramuscularly or subcutaneously. Desmopressin, a synthetic analog, is available for oral and intranasal administration.
What are the side effects of vasopressin?
Common side effects of vasopressin include vasoconstriction, hypertension, bradycardia, cardiac arrhythmias, myocardial ischemia, hyponatremia, and water intoxication. Monitor patients closely for these adverse effects.

Last updated: 2026-02-19